Andreas Brandl

15PUBLICATIONS
43CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyPredictive and prognostic markersNumerical modelling and mechanical characterisation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 16, 2025
Multisocietal Consensus on the use of Cytoreductive Surgery and HIPEC for the Treatment of Pseudomyxoma Peritonei: A GRADE Approach for Evidence Evaluation and Recommendation.

Shigeki Kusamura, Edward Levine, Michela Cinquini

|Aug 08, 2025
Multisocietal Consensus on the Use of Cytoreductive Surgery and HIPEC for the Treatment of Epithelial Ovarian Cancer: A GRADE Approach for Evidence Evaluation and Recommendation.

Donnal Brennan, Amy Hawarden, Michela Cinquini

|Nov 29, 2024
Multisocietal Consensus on the Use of Cytoreductive Surgery and HIPEC for the Treatment of Diffuse Malignant Peritoneal Mesothelioma: A GRADE Approach for Evidence Evaluation and Recommendation.

Shigeki Kusamura, Michela Cinquini, David Morris

|Jul 16, 2024
Interprofessional education in cancer care - a scoping review.

Virpi Sulosaari, Nikolina Dodlek, Andreas Brandl

|May 15, 2024
Neoadjuvant treatment of colorectal cancer: comprehensive review.

Henry G Smith, Per J Nilsson, Benjamin D Shogan

|Oct 31, 2023
Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I Trial.

Beate Rau, Hauke Lang, Alfred Koenigsrainer

Pageof 3

Frequent Collaborators

3 joint publications

Marcello Guaglio

3 joint publications

Michela Cinquini

3 joint publications

Shigeki Kusamura

2 joint publications

Beate Rau